Skip to Content Skip to Footer
Shawn Smith, PharmD

Shawn Smith, PharmD

Assistant Professor

College of Pharmacy

shawnsmith@westernu.edu

Phone: (909) 469-8363

  • Education
    • PGY2 Ambulatory Care Pharmacy Residency, Virginia Commonwealth University School of Pharmacy, 2018-2019
    • PGY1 Ambulatory Care Pharmacy Residency, University of California at San Diego Health, 2017-2018
    • Doctor of Pharmacy, 2017, Loma Linda University
    • Pre-Pharmacy Studies, Bloomsburg University of Pennsylvania
  • Teaching Experience

    Dr. Smith’s current teaching responsibilities include coordination of the physical assessment portion of the curriculum. He also teaches cardiometabolic disease state management with a focus on diabetes mellitus, hypertension, dyslipidemia, heart failure, and smoking cessation.

  • Research Interest

    Dr. Smith’s research and practice interests involve engaging in community partnerships to develop innovative practice models in underserved populations to improve access to primary healthcare services and medications.

  • Research Grant
    • "COVID-19 Prevention and Treatment in the Homeless Population” City of Victorville. Community Development Block Grant.

    • "Improving Access to Behavioral Health Services in Homeless Shelters” National Association of Free and Charitable Clinics & CVS Health Foundation.

    • "Equitable Access to COVID-19 Testing” National Association of Free and Charitable Clinics & Center for Disaster Philanthropy.

    • "Chronic Disease Management for Uninsured High Desert Residents” Kaiser Foundation Hospitals Fontana.

    • City of Victorville Community Development Block Grant: CARES ACT
    • High Desert Community Foundation COVID-19 Relief Fund
    • Center for Disaster Philanthropy COVID-19 Relief
    • Pollination Project COVID-19 Relief
    • Inland Empire Community Foundation COVID-19 Relief
    • United Way COVID-19 Relief Fund
  • Awards
    • McKeen Cattell Memorial Award, Journal of Clinical Pharmacology, 2019
    • President’s Award, Loma Linda University School of Pharmacy, 2017
  • Organizations
    • National Association of Free and Charitable Clinics (NAFC)

    • California Association of Free and Charitable Clinics (CAFCC)

    • American Academy of Colleges of Pharmacy (AACP)

    • American Association of Diabetes Educators (AADE)

    • American College of Cardiology (ACC)

    • American College of Clinical Pharmacy (ACCP)

    • The Rho Chi Society: Gamma Rho Chapter

  • Publications

    Nguyen DD, Lu L, Smith SR. Evidence-Based Appraisal of the DAPA-CKD Trial. Journal of Contemporary Pharmacy Practice (2022) 69 (1): 19–24. https://doi.org/10.37901/jcphp21-00011

    Smith SR, Ruiz CW, Ali S, et al. A pharmacist-led collaborative care model for cardiometabolic risk reduction: a case study. ADCES in Practice. 2021;9(3):16-23. https://doi.org/10.1177/2633559X21994855

    Aranda JP, Smith SR, Nguyen HN, Jap C, Gogineni HP. Virtual physical assessment training during the COVID-19 pandemic - student pharmacists’ performance & perceptions. PharmacyEducation (2020) 20(2) 165 – 173. https://doi.org/10.46542/pe.2020.202.165173

    Smith SR, Schwartzman E, Hata M. Team-based hypertension management in outpatient settings. JCOM. 2020;27(3).

    Martino JG, Smith SR, Rafie S, Rafie S, Marienfeld C. Physician and Pharmacist: Attitudes, Facilitators, and Barriers to Prescribing Naloxone for Home Rescue. Am J Addict. 2019; https://doi.org/10.1111/ajad.12982

    Sisson EM, Kim CJ, Smith SR. AADE Quick Guide to Medications, 9th Edition. Chicago: American Association of Diabetes Educators; 2019. ISBN 978-1-881876-52-6

    Dixon DL, Pamulapati LG, Bucheit JD, Sisson, EM, Smith SR, Kim CJ, Wohlford GF, Pozen J. Recent Updates on the Use of PCSK9 Inhibitors in Patients with Atherosclerotic Cardiovascular Disease. Curr Atheroscler Rep. 2019;21(5):16.
    https://doi.org/10.1007/s11883-019-0778-6

    Hill L, Smith SR, Karris MY. Profile of bictegravir/emtricitabine/tenofovir alafenamide fixed dose combination and its potential in the treatment of HIV-1 infection: evidence to date. HIV AIDS (Auckl). 2018;10:203-213.
    https://doi.org/10.2147/HIV.S145529

    Truong J, Smith SR, Veillette JJ, Forland SC. Individualized pharmacokinetic dosing of vancomycin reduces time to therapeutic trough concentrations in critically ill patients. J Clin Pharmacol. 2018;58(9):1123-1130.
    https://doi.org/10.1002/jcph.1273